Baytshtok V, DiMattia M, Lima C
bioRxiv. 2025; .
PMID: 39763778
PMC: 11703149.
DOI: 10.1101/2024.10.04.616749.
Ikeda Y, Yuki R, Saito Y, Nakayama Y
FASEB J. 2024; 38(24):e70261.
PMID: 39698932
PMC: 11656513.
DOI: 10.1096/fj.202401560RR.
Xie H, Liu X, Li S, Wang M, Li Y, Chen T
Front Endocrinol (Lausanne). 2024; 15:1434338.
PMID: 39588331
PMC: 11586182.
DOI: 10.3389/fendo.2024.1434338.
Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X
J Cancer Res Clin Oncol. 2024; 150(7):374.
PMID: 39080077
PMC: 11289042.
DOI: 10.1007/s00432-024-05881-5.
Ikliptikawati D, Makiyama K, Hazawa M, Wong R
Int J Mol Sci. 2024; 25(13).
PMID: 39000572
PMC: 11242911.
DOI: 10.3390/ijms25137465.
eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production.
Mars J, Culjkovic-Kraljacic B, Borden K
Nucleus. 2024; 15(1):2360196.
PMID: 38880976
PMC: 11185188.
DOI: 10.1080/19491034.2024.2360196.
RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity.
Li J, Su L, Jiang J, Wang Y, Ling Y, Qiu Y
Int J Mol Sci. 2024; 25(1).
PMID: 38203469
PMC: 10778711.
DOI: 10.3390/ijms25010299.
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
Soliman T, Keifenheim D, Parker P, Clarke D
J Cell Biol. 2023; 222(12).
PMID: 37955972
PMC: 10641588.
DOI: 10.1083/jcb.202209125.
Distinct Mitotic Functions of Nucleolar and Spindle-Associated Protein 1 (NuSAP1) Are Controlled by Two Consensus SUMOylation Sites.
Damizia M, Altieri L, Costanzo V, Lavia P
Cells. 2023; 12(21).
PMID: 37947624
PMC: 10650578.
DOI: 10.3390/cells12212545.
Nuclear transport proteins: structure, function, and disease relevance.
Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q
Signal Transduct Target Ther. 2023; 8(1):425.
PMID: 37945593
PMC: 10636164.
DOI: 10.1038/s41392-023-01649-4.
Aspergillus SUMOylation mutants exhibit chromosome segregation defects including chromatin bridges.
Zhang J, Qiu R, Bieger B, Oakley C, Oakley B, Egan M
Genetics. 2023; 225(4).
PMID: 37724751
PMC: 10697819.
DOI: 10.1093/genetics/iyad169.
Exploring the molecular and clinical spectrum of COVID-19-related acute necrotizing encephalopathy in three pediatric cases.
Wu D, Zheng Y, Li Y, Peng M, Lin H, Wang K
J Hum Genet. 2023; 68(11):769-775.
PMID: 37491516
DOI: 10.1038/s10038-023-01171-z.
Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma.
Qian L, Liang Z, Wang Z, Wang J, Li X, Zhao J
J Mol Cell Biol. 2023; 15(5).
PMID: 37204028
DOI: 10.1093/jmcb/mjad027.
Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2.
Di Cesare E, Moroni S, Bartoli J, Damizia M, Giubettini M, Koerner C
Cells. 2023; 12(3).
PMID: 36766713
PMC: 9913629.
DOI: 10.3390/cells12030372.
Regulation of the mitotic chromosome folding machines.
Dekker B, Dekker J
Biochem J. 2022; 479(20):2153-2173.
PMID: 36268993
PMC: 9704520.
DOI: 10.1042/BCJ20210140.
Two type I topoisomerases maintain DNA topology in human mitochondria.
Menger K, Chapman J, Diaz-Maldonado H, Khazeem M, Deen D, Erdinc D
Nucleic Acids Res. 2022; 50(19):11154-11174.
PMID: 36215039
PMC: 9638942.
DOI: 10.1093/nar/gkac857.
Mitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity.
Hu G, Chen Y, Yang X, Wang Y, He J, Wang T
Cell Death Dis. 2022; 13(7):640.
PMID: 35869062
PMC: 9307842.
DOI: 10.1038/s41419-022-05063-6.
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells.
Hanel W, Lata P, Youssef Y, Tran H, Tsyba L, Sehgal L
Exp Hematol Oncol. 2022; 11(1):40.
PMID: 35831896
PMC: 9277803.
DOI: 10.1186/s40164-022-00293-y.
The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.
Lotz C, Lamour V
Cancer Drug Resist. 2022; 3(2):149-160.
PMID: 35582608
PMC: 9090595.
DOI: 10.20517/cdr.2019.114.
SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases.
Sun Y, Nitiss J, Pommier Y
Front Mol Biosci. 2022; 9:871161.
PMID: 35463961
PMC: 9019546.
DOI: 10.3389/fmolb.2022.871161.